Overview
Clinical Benefits
- Myostatin inhibition
- Potential muscle hypertrophy
- Improved muscle quality
- Fat loss support
Administration
Subcutaneous or intramuscular injection
Drug class: myostatin inhibitor
Clinical Dosing
Typical dosage
100mcg daily (research protocols)
Starting dose
100mcg
Cadence
Once daily
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-10 | 100mcg once daily |
| Weeks 11+ | STOP — take 12+ weeks off before re-cycling |
Safety Profile
Side effects
- • Limited human safety data
- • Possible cardiac hypertrophy
- • Joint stiffness
- • Unknown long-term effects
Contraindications
- • Cardiac conditions
- • Pregnancy
- • Minors
- • Active cancer
Frequently asked questions
Follistatin 344 is most commonly researched for: Myostatin inhibition, Potential muscle hypertrophy, Improved muscle quality, Fat loss support.
Ready to build a protocol with Follistatin 344?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.